Company: RNGE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001641172-25-001343
Chunk: 811

Company: RANGE IMPACT, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 811
---
 of compensation expense for non-employees is in the same period and manner as if the Company had paid
cash for the services. The Company recognizes the fair value of stock-based compensation within its Consolidated Statements of Operations
with classification depending on the nature of the services rendered.

The
fair value of the Company’s stock options is estimated using the Black-Scholes-Merton Option Pricing model, which uses certain
assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or restricted stock, and future
dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model. The assumptions
used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

    F-11

Basic
and Diluted Income (Loss) Per Share

Basic
income (loss) per share is computed by dividing the net loss applicable to common stockholders by the weighted average number of outstanding
common shares during the period. Shares of restricted stock are included in the basic weighted average number of common shares outstanding
from the time they vest. Diluted income (loss) per share is computed by dividing net income (loss) applicable to common stockholders
by the weighted average number of common shares outstanding plus the number of additional common shares that would have been outstanding
if all dilutive potential common shares had been issued. Diluted loss per share excludes all potential common shares if their effect
is anti-dilutive. The following potentially dilutive shares were excluded from the shares used to calculate diluted earnings per share
as their inclusion would be anti-dilutive:

SCHEDULE
OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

    December
    31, 2024  
    December
    31, 2023 
  
    Options 
     11,594,210  
     11,392,544 
  
    Warrants 
     3,166,667  
     3,313,335 
  
    Total 
     14,760,877  
     14,705,879 
  
    Anti-dilutive loss per share 
     14,760,877  
     14,705,879 

Patents
and Patent Application Costs

Although
the Company believes that its patents and underlying technology have continuing value, the amount of future benefits to be derived from
the